Granules Company Profile

What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?

GRANULES has sixty-two approved drugs.

There is one tentative approval on GRANULES drugs.

Summary for Granules

US Patents:	0
Tradenames:	49
Ingredients:	49
NDAs:	62
Patent Litigation for Granules:	See patent lawsuits for Granules

Drugs and US Patents for Granules

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Granules	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	217027-002	Jan 23, 2023	AB1	RX	No	No
Granules	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	CAPSULE;ORAL	078143-001	Jan 16, 2008		DISCN	No	No
Granules	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	214608-003	Dec 23, 2021	AB	RX	No	No
Granules	GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE	guaifenesin; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	216082-001	Aug 22, 2022		DISCN	No	No
Granules	SERTRALINE HYDROCHLORIDE	sertraline hydrochloride	TABLET;ORAL	078403-003	Jan 8, 2008	AB	RX	No	No
Granules	GUAIFENESIN	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	213420-001	May 8, 2020		OTC	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Granata Bio
• Granulation Tech
• Granules
• Granules India